Tendyne Holdings, Inc.

Tendyne Holdings, Inc. is an Abbott-owned medical device subsidiary behind the Tendyne Transcatheter Mitral Valve System, a minimally invasive replacement system for symptomatic severe mitral valve dysfunction associated with severe mitral annular calcification. Abbott acquired Tendyne in 2015, and the system is now approved in the United States for eligible patients.